AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
70.38
-0.58 (-0.82%)
At close: May 28, 2025, 4:00 PM
70.00
-0.38 (-0.54%)
After-hours: May 28, 2025, 5:41 PM EDT
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
$583,054
Profits / Employee
$82,418
Market Cap
216.88B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AZN News
- 3 days ago - Why AstraZeneca May Be 2025's Most Underrated Pharma Stock - Seeking Alpha
- 6 days ago - Aptar Digital Health Announces Licensing Agreement With AstraZeneca to Develop AI-Powered Screening Algorithms - Business Wire
- 7 days ago - AstraZeneca's record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer - Business Wire
- 9 days ago - Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma - Business Wire
- 10 days ago - 35 Barron's Pro-Picks: One Ideal May DiviDog - Seeking Alpha
- 14 days ago - BioInvent Announces Updated Phase 2a Triple Combination Arm Data of BI-1206, rituximab, and Calquence for the Treatment of Non-Hodgkin's Lymphoma - Accesswire
- 15 days ago - AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025 - Business Wire
- 16 days ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ